ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1364	National Cancer Institute	Html	en	Sleep Disorders (PDQ®)–Health Professional Version	Expert-reviewed information summary about causes and management of sleep disorders in people with cancer.	slow wave sleep 0.645037 sleep difficulty 0.586858 circadian sleep disorder 0.585999 sleep disturbance 0.734742 general sleep 0.627531 self-reported sleep 0.586211 sleep disturbances 0.78937 sleep environment 0.599417 general sleep hygiene 0.610843 sleep history 0.590036 poor sleep hygiene 0.618457 sleep patterns 0.707388 individual sleep patterns 0.650508 sleep cycle. 0.613137 sleep diary 0.632064 subjective sleep quality 0.612249 sleep disruption 0.616368 severe sleep 0.619271 sleep medicine report 0.579291 Pittsburgh Sleep Quality 0.612644 8-hour sleep period. 0.649042 General Sleep Disturbance 0.626985 different sleep trajectories 0.61732 secondary sleep disorders 0.654958	behavioral therapy 0.643973 cancer experience sleep 0.697426 numerous sleep parameters 0.602184 sleep education 0.598942 REM sleep 0.663854 sleep 0.906331 diary-measured sleep variables 0.59623 sleep cycle 0.621195 sleep outcomes 0.569139 sleep medicine 0.672639 common sleep disturbance 0.63638 total sleep time 0.611253 sleep quality 0.73817 sleep disorders 0.662401 progressively deepening sleep 0.64769 Adequate sleep 0.615183 sleep restriction 0.71475 severe sleep disturbances 0.604554 breast cancer 0.670406 insomnia 0.65868 randomized controlled trial 0.60112 severe sleep disorder 0.613455 sleep hygiene 0.685071 NREM sleep 0.616861	CLICK HERE
1581	National Cancer Institute	Html	en	Thyroid Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of thyroid cancer.	thyroid hormone 0.462109 thyroid cells 0.459144 thyroid hormone levels 0.441028 body 0.475956 thyroid nodules 0.440882 thyroid hormone replacement 0.418097 type 0.402327 PDQ cancer information 0.417269 clinical trial search 0.44196 clinical trials 0.712208 thyroid cancer spreads 0.460066 radioactive iodine therapy 0.447344 cancer information summary 0.398763 clinical trial 0.54371 thyroid disease 0.440863 patients 0.405549 fine-needle aspiration biopsy 0.401121 sentinel lymph node 0.409752 thyroid tumor 0.430395 lymph nodes 0.45279 thyroid cancer cells 0.479847 thyroid cancer treatment 0.491155 radiation therapy 0.478836 medullary thyroid cancer 0.563411 tyrosine kinase inhibitor 0.42467	thyroid scan 0.39797 treatment 0.554504 childhood thyroid cancer 0.480138 thyroid nodule 0.461177 follicular thyroid cells 0.442093 metastatic thyroid cancer 0.461409 healthy thyroid 0.426685 undifferentiated thyroid cancer 0.481926 thyroid cancer 0.866042 cancer cells 0.55043 thyroid tissue 0.43819 familial medullary thyroid 0.436692 anaplastic thyroid cancer 0.503212 National Cancer Institute 0.411413 Thyroid hormones 0.426342 external radiation therapy 0.459156 papillary thyroid cancers 0.4232 differentiated thyroid cancer 0.481235 thyroid uses iodine 0.446079 cancer clinical trials 0.453504 stage 0.433394 tumor 0.440267 cancer 0.979846 information 0.45122	CLICK HERE
1704	National Cancer Institute	Html	en	Psychological Stress and Cancer	A fact sheet that describes the effects of stress on the body, the results of research on the relationship between stress and cancer, and information about coping with stress.	Sood AK 0.622496 cancer treatment 0.603243 primary breast cancer 0.597411 Antoni MH 0.570507 human cancer cells 0.605494 family member 0.588007 psychological distress 0.593032 fact sheet 0.615559 mammary fat pads 0.570769 emotional pressure 0.583244 Health care providers 0.574848 risky behaviors 0.581446 cancer metastasis 0.572171 social support 0.574381 triple-negative breast cancer 0.658004 various psychological factors 0.615469 Lutgendorf SK 0.681275 cancer patients 0.656706 cancer survival 0.572148 stress cause cancer 0.708673 blood sugar levels 0.578812 Clinical Oncology 0.599718 speed heart rate 0.575901 ovarian carcinoma patients 0.577415	higher rates 0.57609 specific psychological conditions 0.622117 Psychological Bulletin 0.579687 elevated tumor norepinephrine 0.576809 psychological stress 0.974362 beta blockers 0.5732 normal life activities 0.583211 physical health problems 0.585785 drinking alcohol 0.576593 cancer outcomes 0.570999 biobehavioral signaling pathways 0.570101 stress management techniques 0.670628 clinical health psychologist 0.575253 Cancer Research 0.5705 stress hormone norepinephrine 0.675379 poorer clinical outcomes 0.584728 stress hormones 0.675405 people 0.602029 certain stress hormones 0.663467 New patient-centered care 0.571423 close family member 0.58133 Related Resources 0.579385 et al 0.674807 Related Resources section 0.573303	CLICK HERE
1729	National Cancer Institute	Html	en	Hyperthermia in Cancer Treatment	A fact sheet that defines hyperthermia (treating tumors with heat) and its side effects.	cancer treatment 0.403898 peritoneal cavity temperature 0.426528 External applicators 0.382217 whole-body hyperthermia 0.729094 van der Zee 0.371709 Clinical Radiation Oncology. 0.380706 tumor location 0.365525 regional hyperthermia 0.5725 hyperthermic peritoneal perfusion 0.490656 metastatic cancer 0.36336 Gibbs FA Jr 0.369277 normal tissues 0.422996 cancer therapy 0.407309 hyperthermia treatment 0.61506 bladder cancer 0.363102 Deep tissue approaches 0.386891 clinical trials 0.532546 DeVita VT Jr. 0.371357 interstitial hyperthermia 0.571391 hyperthermia 0.901227 tissue characteristics 0.386571 hot water blankets 0.375371 peritoneal cavity 0.431179 hyperthermia techniques 0.560349 radiation therapy 0.457463	high temperatures 0.42664 primary peritoneal mesothelioma 0.407141 local hyperthermia 0.597761 body cavity 0.386007 cancer cells 0.536875 anticancer drugs 0.424955 Cancer Information Service 0.393124 Libutti SK 0.372166 tumor size 0.36657 certain anticancer drugs 0.383187 B.C. Decker Inc. 0.373174 Samulski TV. Hyperthermia 0.573888 Numerous clinical trials 0.395138 Clinical Trials Information 0.383207 malignant peritoneal mesothelioma 0.399886 body tissue 0.392759 Regional perfusion techniques 0.40208 Bast RC Jr. 0.371129 stomach cancer 0.363295 tumor 0.394758 inserts small needles 0.373242 et al 0.437187 higher temperatures 0.384967 research studies 0.385011	CLICK HERE
1833	National Cancer Institute	Html	es	Tratamiento de los tumores carcinoides gastrointestinales (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores carcinoides gastrointestinales.	metastatic carcinoid tumor 0.417651 carcinoides gi 0.793345 enfermedad cardíaca carcinoide 0.432281 carcinoides duodenales 0.478754 células ec 0.425941 tracto gi 0.460962 Sin embargo 0.46213 tumores carcinoides gi 0.491452 PDQ Tumores neuroendocrinos 0.416768 imaging features with 0.416291 células neuroendocrinas gi 0.414118 marcadores carcinoides 0.432817 Exp Clin Cancer 0.413418 Cancer Res 0.421273 Res Clin Endocrinol 0.414031 Clin Gastroenterol 0.414029 síntomas carcinoides 0.431545 Pract Res Clin 0.438075 síndrome carcinoideo 0.506176 Clin Cancer Res 0.414666 patients with 0.502884 carcinoid tumors 0.605663 Best Pract Res 0.431995 Clin Endocrinol Metab 0.422923 carcinoid heart 0.423722	carcinoides celulares cse 0.43559 carcinoide celular cse 0.415154 tumores carcinoides 0.966863 neuroendocrine tumors 0.59007 TNE pancreáticos 0.414445 gastrointestinal tract 0.419836 tumores carcinoides gastrointestinales 0.615452 Surg Pathol 0.422847 Dig Dis Sci 0.415197 tumores tipo 0.415164 multiple endocrine neoplasia 0.418143 CSE tipo 0.414261 TNE GI 0.460772 tumores neuroendocrinos 0.4479 carcinoides esporádicos gi 0.445952 Surg Oncol 0.418143 with von recklinghausen 0.424868 somatostatin receptor 0.413855 neuroendocrine tumour 0.454787 tumores neuroendocrinos pancreáticos 0.419002 carcinoid tumor with 0.413498 Acad Sci 0.415384 gastrointestinal carcinoids 0.415688 tumores duodenales 0.41576	CLICK HERE
1907	National Cancer Institute	Html	es	Tratamiento de la leucemia linfoblástica aguda en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia linfoblástica aguda en adultos.	siguientes procedimientos 0.512309 células madre 0.745172 posibles factores 0.503357 leucemia linfocítica aguda 0.520357 sudores nocturnos 0.503905 leucemia linfoblástica aguda 0.974441 células madre formadoras 0.514124 hueso compacto 0.512997 neoplasias mieloides 0.503724 vía oral 0.502952 rayos x 0.503057 tirosina cinasa mesilato 0.506883 enlace drugs approved 0.528959 largo plazo 0.502247 cromosoma filadelfia 0.520834 célula madre mieloide 0.525688 células t 0.514618 efectos tardíos 0.513015 células anormales.ampliar aspiración 0.521673 líquido cefalorraquídeo 0.529356 punción espinal.Ampliar 0.503734	National Cancer Institute 0.502969 siguientes riesgos 0.502423 Instituto Nacional 0.509996 célula madre linfoide 0.511194 PDQ Tratamiento 0.507876 general empeora 0.503285 presente sección 0.502319 leucemia mielógena 0.512372 sistema nervioso central 0.612 Physician Data Query 0.510454 linfocitos t 0.513897 leucemia mieloide aguda 0.535285 siguientes enlaces 0.502726 célula madre 0.560418 células sanguíneas maduras 0.551656 células formadoras 0.516721 Filadelfia".Ampliar Cromosoma Filadelfia 0.507706 terapia posremisión 0.505736 cuidado paliativo 0.502192 siguientes pruebas 0.518516	CLICK HERE
1945	National Cancer Institute	Html	es	Efectos tardíos del tratamiento anticanceroso en la niñez (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de los problemas de salud que aparecen una vez que termina el tratamiento del cáncer.	cancer statistics 0.312893 among adult survivors 0.309342 health insurance 0.30576 childhood leukemia survivors 0.314627 Marrow Transplant Survivor 0.306695 largo plazo 0.353459 Cancer Survivor cohort 0.310798 CA Cancer 0.308516 group long-term follow-up 0.307764 mortality among 5-year 0.309974 health conditions 0.3067 young adult cancers 0.387348 late mortality 0.309117 Ness KK 0.312945 among childhood cancer 0.329959 adult survivors 0.341543 Hudson MM 0.322937 among survivors 0.313213 British Childhood Cancer 0.315849 utilization among long-term 0.306183 childhood cancer 0.973475 cancer survivor study 0.608871 late effects 0.312383 SEER Cancer Statistics 0.308306 long-term survivors 0.338777	health care utilization 0.307102 Survivor Study cohort 0.310239 chronic health conditions 0.305835 among adolescent survivors 0.308292 Care Cancer 0.309376 among 5-year survivors 0.328567 Pediatr Blood Cancer 0.42011 oncology group long-term 0.310223 adolescent cancers 0.313982 efectos tardíos 0.375703 survivors research program 0.306998 report from 0.396085 National Cancer Institute 0.308232 Oeffinger KC 0.306859 health care 0.314251 mortality among survivors 0.308816 Clin Oncol 0.375569 childhood cancer survivor 0.872407 medical care 0.307228 among long-term survivors 0.315379 late mortality among 0.306982 long-term follow-up guidelines 0.320022 Outcomes Among Childhood 0.309917 children's oncology group 0.433388	CLICK HERE
3876	National Cancer Institute	Html	en	The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)	Apply for the NCI F99/K00 Award that helps late-stage doctoral candidates finish their training and then transition into cancer-focused research positions.	K00 phase institution 0.388613 applicant institution 0.265884 Research Doctoral candidates 0.275389 Funding Opportunity Announcement 0.903132 research supplies 0.244496 Career Development Award 0.350987 k00 award 0.331719 Ph.D. dissertation requirements 0.237088 phase institutional representative 0.335728 project award period 0.253621 indirect costs 0.425626 NCI F99/K00 Predoc 0.307817 Institutional Allowance 0.281782 Career Development Support 0.249362 Research Career Development 0.347168 k00 phase 0.762118 Research Plan section 0.261319 career development skills 0.241364 health-related Ph.D. program 0.243519 F99 primary sponsor 0.23706 Research Service Award 0.312163 Individual Research Career 0.265006 mandatory NCI-sponsored conference 0.307767 Opportunity Announcement instructions 0.260896 career development research 0.317687	dissertation research project 0.396866 Ph.D. degree program 0.256222 valid U.S. visas 0.237157 Postdoctoral Fellow Transition 0.248842 Application Guide 0.311615 NCI Predoctoral 0.237727 F99 phase 0.471921 dissertation research training 0.299174 program staff 0.238571 Program Staff Contact 0.236142 Research Strategy 0.247855 F99/K00 Award 0.359733 F99 grant mechanism 0.235643 assigned NCI Program 0.270275 Development Award Supplemental 0.254853 F99 award 0.269956 fringe benefits 0.272186 valid U.S. visa 0.254123 career development 0.562023 Research Plan Sections 0.252481 Fellowship Applicant Section 0.257658 F99/K00 Award application 0.300758 health-related research field 0.279872 Postdoctoral Research Direction 0.273719	CLICK HERE
16849	National Cancer Institute	Html	en	Earlier Detection and Diagnosis	Winning the battle in cancer is by way of its earlier detection. Find out here how nanotechnology for cancer can enable the next generation of diagnostics.	molecular contrast agents 0.744126 magnetic resonance 0.73913 gold nanoparticles 0.758974 contrast agents 0.928653 specific tumor type 0.759045 nanoparticles 0.799664 Kettering Cancer Center 0.72147 single cancer cell 0.739114 prostate cancer cells 0.750158 local tumor response 0.753856 self-assemblying nanoparticles 0.709894 image contrast agents 0.719631 current nanoscale imaging 0.726633 tumor specific tissue 0.778585 tumor types 0.710578 magnetic resonance imaging 0.73549 tissue biopsies 0.710788 single cell level 0.706857 tumor tissue 0.754041 cancer cells 0.798935 magnetic nanoparticles 0.748727 Current imaging methods 0.720015 surgical resection 0.752605 molecular imaging agents 0.749026 imaging contrast agents 0.752812	Bioactivatable nanoparticles 0.713538 tumor pre-seeding 0.710938 novel imaging modalities 0.716395 tumor growth 0.708481 clinical cancer imaging 0.759447 tumor cells 0.829828 optical imaging contrast 0.737025 lung cancer patients 0.707897 Stanford University 0.729305 modern imaging modalities 0.717085 biological signatures 0.716262 cancer detection 0.708688 clinical cancer treatment 0.738765 brain tumor 0.708929 single circulating tumor 0.753922 cancer cell death 0.775613 Raman spectroscopic imaging 0.712792 imaging modalities 0.740521 MRI-PAT-Raman nanoparticles 0.710131 silica-hybrid nanoparticles 0.709652 prostate cancer 0.754477 tumor DNA 0.744446 cancer patient treatment 0.749464 cell-free tumor DNA 0.731784	CLICK HERE
17276	National Cancer Institute	Html	es	Su propio cuidado	Cuidar a alguien con cáncer avanzado trae desafíos y preocupaciones nuevas. Es importante que también se cuide a usted mismo y que pida ayuda.	Lotsa Helping Hands 0.77931 busque ayuda 0.925738	tanta emoción 0.963692	CLICK HERE